Nielsen, A. S. (2015). Advances in the management of relapsing–remitting multiple sclerosis: Role of oral dimethyl fumarate (BG-12). Degener Neurol Neuromuscul Dis.
Citación estilo ChicagoNielsen, A Scott. "Advances in the Management of Relapsing–remitting Multiple Sclerosis: Role of Oral Dimethyl Fumarate (BG-12)." Degener Neurol Neuromuscul Dis 2015.
Cita MLANielsen, A Scott. "Advances in the Management of Relapsing–remitting Multiple Sclerosis: Role of Oral Dimethyl Fumarate (BG-12)." Degener Neurol Neuromuscul Dis 2015.
Precaución: Estas citas no son 100% exactas.